Bio-Techne Corporation

NASDAQ: TECH · Real-Time Price · USD
54.22
0.93 (1.75%)
At close: Aug 19, 2025, 11:49 AM

Bio-Techne Cash Flow Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Net Income
22.59M 34.89M 33.6M 40.58M 49.05M 27.47M 50.99M 75.48M 70.22M 50.01M 89.73M 61.91M 60.14M 72.06M 68.98M 14.64M 45.4M 46.14M 33.4M
Depreciation & Amortization
27.57M 27.08M 28.14M 28.06M 27.31M 27.8M 28.54M 26.92M 26.97M 26.7M 26.64M 25.87M 25.37M 25.1M 24.73M 24.67M 21.1M 20.88M 21.09M
Stock-Based Compensation
11.39M 14.71M 10.18M 7.06M 8.13M 12.75M 10.09M -2.08M 10.11M 16.74M 14.46M 8.41M 8.07M 13.97M 11.74M 9.81M 10.64M 15.58M 12.95M
Other Working Capital
3.62M -707K -20.58M -6.31M 22.52M 10.33M -10.99M 123.34M -2.63M 6.35M -28.18M 6.2M -38.77M 15.36M -48.24M 32.25M -13.37M 8.76M -10.32M
Other Non-Cash Items
-15.02M 3.55M 7.04M 19.59M 86.68M 7.04M -20.75M -91.54M -1.09M -10.09M -47.06M 7.04M 13.6M -23.73M -8.9M 58.19M 17.28M -5.85M 4.4M
Deferred Income Tax
-5.41M -8.08M -5.34M -9.55M -7.58M -10.72M -11.59M -6.92M -16.29M -1.6M -4.77M -1.07M 655K 1.83M 5.41M -21.41M -6.24M 668K -452K
Change in Working Capital
n/a 12.2M -9.74M -10.24M 1.33M 18.78M 2.1M 81.53M -39.39M -17.38M -22.93M 6.94M -34.7M 11.77M -53.52M 36.12M -13.33M 11.84M -5.37M
Operating Cash Flow
41.12M 84.35M 63.89M 75.5M 80.99M 83.12M 59.38M 83.39M 50.53M 64.38M 56.08M 102.72M 73.13M 100.99M 48.43M 122.02M 74.87M 89.27M 66.01M
Capital Expenditures
-10.12M -6.82M -9.17M -17.98M -16.44M -14.86M -13.59M -10.83M -11.75M -6.11M -9.56M -13.57M -15.1M -10.17M -6.07M -11.32M -10.6M -11.45M -10.94M
Cash Acquisitions
n/a n/a n/a 167.56M n/a -3.28M -164.28M -101.18M -130.82M n/a -83.36M -21.94M n/a n/a 1.05M -215.59M -556K -9.77M n/a
Purchase of Investments
n/a n/a n/a 7.96M n/a -5.53M -2.43M 20.5M 20.5M 14.5M -14.5M -5M -34.5M -11.5M -13.5M -556K -12.5M -945K -26.24M
Sales Maturities Of Investments
n/a n/a 1.08M 9.17M -2.15M 5.53M 23.76M -29.16M -26.51M 12M 73.22M -15M 13.61M n/a 12.45M 67.88M 23.23M 14.11M 29.04M
Other Investing Acitivies
1.25M 1.79M -13.6M -175.52M 2.15M -5.53M 2.43M 115.92M -92.52M -20.5M 14.51M -5M -34.5M -13.5M -2.1M 556K 556K -10.32M 2.8M
Investing Cash Flow
-8.87M -5.03M -21.68M -8.81M -16.44M -23.67M -154.11M -4.76M -241.1M -109K -19.69M -18.57M -35.99M -35.17M -7.12M -226.9M 129K -8.6M -8.14M
Debt Repayment
30M n/a -19M -70M -58M 7M 90M -20M 170M -64.66M 8.66M -3.13M -23.13M -18.13M -41.13M 125.88M -16.13M -92.13M -33.13M
Common Stock Repurchased
-100.05M n/a n/a -402K -168K -80.04M -20.23M -39K -11M -5.03M -19.56M -58.82M -60.84M -41.29M -23.25M -19.34M -43.18M n/a n/a
Dividend Paid
-12.58M -12.74M -12.69M -12.63M -12.58M -12.56M -12.65M -12.6M -12.58M -12.56M -12.54M -12.54M -12.58M -12.58M -12.49M -12.45M -12.45M -12.39M -12.34M
Other Financial Acitivies
-291K -71.1M -4.98M 22.93M 18.16M 4.2M -5.83M 8.38M -6.58M 5.03M 9.49M -55K 12.47M 18.62M 13.93M 4.26M 16.52M 14.44M 10.53M
Financial Cash Flow
-68.05M -83.84M -11.57M -60.09M -52.42M -81.4M 71.51M -24.22M 150.84M -72.19M -31.81M -65.73M -84.06M -53.38M -39.68M 117.69M -55.23M -90.08M -34.93M
Net Cash Flow
-36.88M -9.99M 35.75M 11.88M 9.78M -18.53M -31.91M 53.29M -37.4M -575K -7.31M 11.75M -51.02M 15.52M -2.77M 12.96M 20.61M -3.88M 22.78M
Free Cash Flow
31M 77.53M 54.72M 57.52M 64.55M 68.25M 45.79M 72.56M 38.79M 58.27M 46.52M 89.15M 58.03M 90.83M 42.36M 110.7M 64.26M 77.82M 55.07M